Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer

BACKGROUND: Stereotactic ablative radiotherapy (SABR) shows a remarkable local control of non-small cell lung cancer (NSCLC) metastases, partially as a result of host immune status. However, the predictors of immune cells for tumor response after SABR are unknown. To that effect, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Hu, Qinyong, Hu, Kai, Su, Huichao, Shi, Fang, Kong, Li, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458628/
https://www.ncbi.nlm.nih.gov/pubmed/30971280
http://dx.doi.org/10.1186/s12967-019-1872-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458628/
https://www.ncbi.nlm.nih.gov/pubmed/30971280
http://dx.doi.org/10.1186/s12967-019-1872-9

Ejemplares similares